Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Bispidine antiarrhythmic agents from AstraZeneca

Feb. 5, 2001

Influence of EGIS-7229 on myocardial refractoriness to electrical stimulation

Feb. 5, 2001

BSF-302146 may have potential for preventing restenosis following CABG surgery

Feb. 2, 2001

Bradykinin fragment may offer a novel therapeutic strategy for septic shock

Jan. 31, 2001

Nortran's RSD-1235 shows efficacy in canine atrial arrhythmia model

Jan. 31, 2001

Newly designed, highly active SOD mimetic protects against SAO shock

Jan. 31, 2001

Zofenopril reaches market for two cardiovascular indications

Jan. 30, 2001

Isoquinolines as inhibitors of If current for cardiovascular disorders

Jan. 29, 2001

Phase II results with rFGF-2 in PAD reported

Jan. 29, 2001

Feasibility study commences for Medusa-delivered relaxin

Jan. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...